Keliximab
Keliximab
Keliximab (pronounced ke-lix-i-mab) is a monoclonal antibody used in the treatment of certain autoimmune diseases. It is a type of biologic therapy that targets specific proteins in the body to help control the immune response.
Etymology
The term "Keliximab" is derived from the Greek words "kelix", meaning "bud", and "mab", an abbreviation for "monoclonal antibody". This reflects the drug's function as a monoclonal antibody that targets specific proteins in the body.
Usage
Keliximab is used in the treatment of autoimmune diseases such as rheumatoid arthritis and psoriasis. It works by targeting and neutralizing specific proteins in the body that are involved in the immune response, thereby helping to control the symptoms of these diseases.
Related Terms
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells. They are used in cancer treatment and other therapies.
- Autoimmune disease: A condition in which your immune system mistakenly attacks your body.
- Rheumatoid arthritis: A chronic inflammatory disorder affecting many joints, including those in the hands and feet.
- Psoriasis: A common skin condition that speeds up the life cycle of skin cells.
See Also
External links
- Medical encyclopedia article on Keliximab
- Wikipedia's article - Keliximab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski